XM does not provide services to residents of the United States of America.
R
R

Resmed


News

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Carnival Corp CCL.N +5.0% 3M Co MMM.N +4.7% Steel Dynamics Inc STLD.OQ +4.6% Nucor Corp NUE.N +4.4% Albemarle Corp ALB.N +4.1% Bottom Performers Percent Change APA Corp (US) APA.OQ -4.3% Centene Corp CNC.N -3.3% Resmed Inc RMD.N -3.2%
S
U
D
R

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Albemarle Corp ALB.N +5.3% ON Semiconductor Corp ON.OQ +4.6% Delta Air Lines Inc DAL.N +4.3% United Airlines Holdings Inc UAL.OQ +4.2% Estee Lauder Companies Inc EL.N +4.1% Bottom Performers Percent Change APA Corp (US) APA.OQ -4.0% Ce
O
U
U
D
E
R

Resmed Inc reports results for the quarter ended in September 30 - Earnings Summary

Resmed Inc reports results for the quarter ended in September 30 - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.20​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.64. The mean expectation of ten analysts for the quarter was for earnings of $2.04 per share.
R

U.S. STOCKS Nvidia, Tesla, Meta

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Tesla, Meta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq rallied to a fresh intraday record on Friday, lifted by megacaps as Treasury yields slipped from the week's high while investors looked ahead to quarterly results from some of Wall Street's biggest companies next week.
C
N
N
N
T
L
W
U
U
A
H
L
M
R
U

U.S. STOCKS Intel, Colgate-Palmolive, Mohawk Industries

BUZZ-U.S. STOCKS ON THE MOVE-Intel, Colgate-Palmolive, Mohawk Industries Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The main U.S. indexes rose on Friday, as Treasury yields slipped from the week's high and relieved the pressure on megacaps, and investors awaited quarterly results from some of Wall Street's biggest companies next week.
A
C
I
N
N
P
L
W
U
U
A
H
L
M
R
U

U.S. STOCKS Capri Holdings, Deckers Outdoor, Spirit Airlines

BUZZ-U.S. STOCKS ON THE MOVE-Capri Holdings, Deckers Outdoor, Spirit Airlines Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to open slightly higher on Friday as Treasury yields eased and investors looked ahead to quarterly results from Wall Street's biggest companies.
A
W
U
A
L
R

ResMed rises after beating quarterly profit estimates

BUZZ-ResMed rises after beating quarterly profit estimates ** Shares of medical device maker ResMed RMD.N rise 4.8% to $250.60 premarket ** Late on Thursday, co reported Q1 adj EPS of $2.20, beating Wall Street estimates of $2.04 - LSEG ** RMD's Q1 rev of $1.22 bln was above estimates of $1.18 bln ** Up to last close, stock up 39% YTD Reporting by
R

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices Oct 24 (Reuters) - ResMed RMD.N beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the company rose about 4% in after- hours trading. The San Diego, California-based company posted adjusted profit of $2.20 per share for the quarter ended September 30, beating estimates of $2.04 per share.
R

Resmed Q1 Adjusted EPS USD 2.2 Vs. IBES Estimate USD 2.04

BRIEF-Resmed Q1 Adjusted EPS USD 2.2 Vs. IBES Estimate USD 2.04 Oct 24 (Reuters) - Resmed Q1 revenue USD 1,200 million vs. IBES estimate USD 1,180 million. Q1 gross margin 58.6% Q1 EPS USD 2.11 Q1 adjusted gross margin 59.2%
R

What to Watch in the Day Ahead - Thursday, October 24

What to Watch in the Day Ahead - Thursday, October 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT United Parcel Service is expected to report a rise in third-quarter profit as rebounding volumes ahead of the holiday season lift revenues with cost cuts potentially offsetting the margin hit f
B
H
S
A
T
S
R
U

Resmed Inc <RMD.N> expected to post earnings of $2.04 a share - Earnings Preview

Resmed Inc expected to post earnings of $2.04 a share - Earnings Preview Resmed Inc RMD.N , RMD is expected to show a rise in quarterly revenue when it reports results on October 24 for the period ending September 30 2024 The San Diego California-based company is expected to report a 7.1% increase in revenue to $1.18 billion from $1.1 billion a year ago, according to the mean estimate from 12 analysts, based on LSEG data.
R

What to Watch in the Week Ahead and on Monday, October 21

What to Watch in the Week Ahead and on Monday, October 21 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of Dallas President Lorie Logan will speak and participate in a moderated question-and-answer session before the 2024 SIFMA (Securities Industry and Financial
A
A
B
B
C
D
H
M
N
N
R
V
A
C
T
T
T
U
D
S
S
R
R
U

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp
A
P
C
L
R

Resmed Unveils New Five-Year Financial Outlook

BRIEF-Resmed Unveils New Five-Year Financial Outlook Sept 30 (Reuters) - Resmed Inc RMD.N : RESMED UNVEILS 2030 STRATEGY TO DRIVE GROWTH, PROFITABILITY, AND SHAREHOLDER RETURNS RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES HIGH-SINGLE-DIGIT REVENUE GROWTH RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES EARNINGS GROWTH HIGHER THAN REVENUE GROWTH
R

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change West Pharmaceutical Services Inc WST.N +4.9% Dollar Tree Inc DLTR.OQ +3.3% Bio Rad Laboratories Inc BIO.N +3.2% Bath & Body Works Inc BBWI.N +3.2% General Motors Co GM.N +3.2% Bottom Performers Percent Change Resmed Inc RMD.N -4.8% Ave
D
D
T
U
A
R

U.S. STOCKS United States Steel, Ambac Financial, Apple

BUZZ-U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slipped in volatile trading on Wednesday ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with jitters over the magnitude of the reduction dominating mood.
A
B
C
G
M
N
S
U
U
U
R

U.S. STOCKS Powerfleet, NMI, Vivos Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were flat on Wednesday as investors stepped onto the sidelines ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with bets favoring a 50-basis-point reduction.
B
G
M
N
U
C
U
U
R

ResMed falls as Wolfe Research downgrades to 'underperform' on 1 risks

BUZZ-ResMed falls as Wolfe Research downgrades to 'underperform' on GLP-1 risks ** Shares of medical device maker ResMed RMD.N fall 6.1% to $235.65 ** Brokerage Wolfe Research downgrades to "underperform" from "peer perform", sets PT of $180 * Expect significant risk of disruption in patient demand next year as FDA likely to approve Eli Lilly's LLY
U
R

KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature

BUZZ-KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature ** Brokerage KeyBanc Capital Markets says it views the news of Apple AAPL.O launching sleep apnea detection in its new Watch Series 10, and existing Watch Series 9 and Watch Ultra 2 as positive for medical device makers Resmed RMD.N and Inspire Medical Systems INSP.
A
G
R

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.
N
W
U
U
C
M
R



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.